|
|
||||||||
Hot Topic Review |
Department of Physiology, Royal College of Surgeons in Ireland, St Stephen's Green, Dublin 2, Ireland
| Abstract |
|---|
|
|
|---|
(Received 23 September 2003;
accepted after revision 30 September 2003)
Corresponding author A. Bradford: Department of Physiology, Royal College of Surgeons in Ireland, St Stephen's Green, Dublin 2, Ireland. Email: abradfor{at}rcsi.ie
| Introduction |
|---|
|
|
|---|
Since periods of apnoea and hypopnoea occur intermittently, the condition is associated with chronic intermittent hypoxia (CIH) or asphyxia (CIA). In normal individuals, intermittent hypoxia or asphyxia can occur in severe exercise (Dempsey et al. 1984), air travel (Cottrell, 1986), diving (Elsner, 1989), exposure to altitude (Hurtado, 1960) and during sleep, particularly in neonates (Thach, 1985). Intermittent hypoxia is common during sleep in a large variety of respiratory diseases and postoperatively (Marshall & Wyche, 1972) and it is used in training for sports (Bernardi, 2001) and in the treatment of a variety of clinical conditions (Serebrovskya, 2002).
Despite the considerable relevance of CIH and CIA to humans in health and disease, and although a great deal is known about the physiological effects of chronic continuous hypoxia, it is only in recent years that the physiological effects of CIH and CIA have begun to be studied. In these studies, the patterns of CIH and CIA that have been induced experimentally have varied greatly but there have been few studies that have attempted to mimic the cyclical blood gas changes associated with sleep-disordered breathing. Foremost among these studies has been the experiments of Fletcher and colleagues that have examined the effects of intermittent hypoxia and asphyxia on systemic blood pressure (Fletcher et al. 1992a,b,c, 1995; Fletcher & Bao, 1996; Bao et al. 1997). These authors developed a technique that exposed rats to hypoxia or asphyxia twice per minute for 68 h per day for several weeks. The timing and the blood gas values achieved mimic the blood gas changes that occur in human OSA. These studies clearly demonstrated that CIH and CIA caused an increase in systemic arterial blood pressure. The importance of this observation relates to the association of sleep apnoea and hypertension. More than 50% of sleep apnoea patients have systemic hypertension (Guilleminault et al. 1976) and approximately 30% of patients with primary hypertension have sleep apnoea (Lavie et al. 1985). The rat model of human OSA supports the hypothesis that it is the CIH and CIA associated with OSA that cause sustained systemic hypertension.
However, there is the potential to study the pathophysiological effects of CIH and CIA on a variety of other variables and systems with this model. We have developed a similar model to that of Fletcher and colleagues and have used it to study the effects of CIH and CIA on haematocrit, right ventricular weight and pulmonary arterial pressure (McGuire & Bradford, 1999, 2001), skeletal muscle structure and function (McGuire et al. 2002a,b, 2003), the control of diaphragm and upper airway muscle activity (O'Halloran et al. 2002), medullary respiratory neurone activity (Martial et al. 2003), platelet function (Dunleavy et al. 2003) and cardiac arrhythmias (Dunleavy & Bradford, 2003). The present review will confine itself to the effects of CIH and CIA on haematocrit, pulmonary arterial pressure and skeletal muscle structure and function.
Effects of CIH and CIA on haematocrit and pulmonary arterial pressure
To induce CIH, animals are placed in restrainers with their heads in hoods. A steady flow of room air is delivered to the hoods for 15s followed by 100% nitrogen for 15 s in order to reduce hood oxygen concentration to a minimum of value of 68%. This is followed by removal of the nitrogen, reintroduction of air and recovery of hood oxygen concentration to room air values. This reduces arterial blood PO2 to a minimum value of approximately 5565 mmHg (McGuire & Bradford, 1999). This cycle is repeated for 78 h per day for several weeks. To induce CIA, 100% carbon dioxide as well as nitrogen are delivered to the hoods to achieve a maximal hood carbon dioxide concentration of 1014%. This results in a mean maximal end-tidal carbon dioxide value of approximately 64 mmHg (McGuire & Bradford, 2001). In all experiments, age- and weight-matched control animals are placed in identical restrainers and hoods but receive air, which is switched (using identical solenoid valves) to air from a separate source every 15 s using the same flow rates as for the CIH and CIA animals.
When we initially developed these techniques, we wished to use some simple measurements such as haematocrit and heart weight to verify that the animals were responding to the treatments. It is well known that chronic continuous hypoxia increases haematocrit and right ventricular weight but the effects of CIH were unclear. Haematocrit and right ventricular weight are increased by hypoxia for 12 h per day for several weeks (Nattie & Doble, 1984) and by alternating 30-min periods of hypoxia and normoxia for 8 h per day for several weeks (Moore-Gillon & Cameron, 1985). However, in general, Fletcher and coworkers found that haematocrit and right ventricular weight were not affected (Fletcher et al. 1992a, 1995) although in some experiments, they did report an increase in either haematocrit without any change in right ventricular weight (Fletcher et al. 1992b) or an increase in right ventricular weight without any change in haematocrit (Fletcher et al. 1992c).
We found that there was an unequivocal increase in haematocrit (44.3 ± 2.0% at day 0; 50.3 ± 1.3% at day 35, Fig. 1A) and right ventricular weight (right ventricular/body weight ratio at day 35: control, 0.55 ± 0.07; CIH, 0.67 ± 0.05 mg g1; Fig. 1B) in response to CIH (McGuire & Bradford, 1999). The increase in haematocrit was present after 1 week of treatment and remained elevated for the 5-week duration of treatment with intermittent hypoxia. The increase in right ventricular weight suggests that there is also an increase in pulmonary arterial pressure in these animals (Rabinovitch et al. 1979). In mice, it was shown recently that CIH increases haematocrit, right ventricular weight and right ventricular systolic pressure, an index of pulmonary arterial pressure (Fagan, 2001). The relevance of this to OSA is that the prevalence and pathogenesis of raised haematocrit and pulmonary hypertension in OSA is a matter of some debate and the numbers of OSA patients reported with elevated haematocrit and pulmonary arterial pressure are variable (Bradley et al. 1985; Weitzenblum et al. 1988; Goldman et al. 1991; Hoffstein et al. 1994; Laks et al. 1995; Chaouat et al. 1996; Sanner et al. 1997). One possible explanation for this variability could be the confounding effect of hypercapnia because hypoxia is sometimes accompanied by hypercapnia during apnoeas. In our experiments, the animals were hypoxic but this was accompanied by hypocapnia rather than hypercapnia as a result of reflex hyperventilation in response to the hypoxia. Since chronic continuous hypercapnia prevents the increase in haematocrit and pulmonary arterial pressure caused by chronic continuous hypoxia (Ooi et al. 2000), it is possible that CIA might not cause an increase in haematocrit and pulmonary arterial pressure due to a protective effect of intermittent hypercapnia. However, when we repeated these experiments with CIA, we found that CIA also caused an increase in haematocrit (45.2 ± 1.0% at day 0; 51.5 ± 1.5% at day 35, Fig. 2A), red blood cell count (7.9 ± 0.4 x 106 mm3 at day 0; 11.1 ± 0.4 x 106 mm3 at day 21), haemoglobin concentration (14.5 ± 0.2 g% at day 0; 16.5 ± 0.5 g% at day 35) and right ventricular weight (right ventricular/body weight ratio at day 35: control, 0.53 ± 0.05 mg g1; CIA, 0.63 ± 0.01 mg g1, Fig. 2B) in a manner similar to that for CIH (McGuire & Bradford, 2001). We also measured pulmonary arterial pressure (Fig. 2C) and found that this too was elevated (control, 20.7 ± 6.8; CIA, 31.3 ± 7.2 mmHg, McGuire & Bradford, 2001). It has been suggested that increased haematocrit and pulmonary hypertension only occur in OSA patients who also have daytime hypoxaemia (Chaouat et al. 1996). However, there have been reports of raised haematocrit and pulmonary arterial pressure in OSA patients with little or no daytime hypoxia (Sajkov et al. 1994; Laks et al. 1995) and the present results show that CIH and CIA cause erythropoiesis, right ventricular hypertrophy and pulmonary hypertension in the absence of intervening periods of continuous hypoxia.
|
|
In OSA, the UA collapses during inspiration because of a failure of UA muscles to dilate and stabilize the UA (Remmers et al. 1978; Brouillette & Thach, 1979; McNicholas, 1990). The reasons for this failure are probably multifactorial, involving factors such as reduced central drive to UA muscles (Remmers et al. 1978) and abnormal reflex control of UA patency (McNicholas et al. 1984, 1987). However, there is also evidence for UA muscle structural abnormalities in humans with OSA (Stauffer et al. 1999; Series et al. 1995, 1996) and in the English bulldog, an animal model of OSA (Petrof et al. 1994). We wondered whether these structural changes manifested themselves as alterations in function and whether these changes were a cause or an effect of OSA. In general, the reported structural changes involved an increase in fast-twitch fibres (Petrof et al. 1994; Series et al. 1995, 1996; Stauffer et al. 1999). It has been suggested that this is due to increased UA muscle load and drive (Petrof et al. 1994; Series et al. 1995). However, although the effects of chronic continuous hypoxia on skeletal muscle structure are controversial, it has been reported to increase fast fibres in rat limb muscles (Bigard et al. 1991). Furthermore, muscle oxidative capacity and mitochondial volume density is low following long-term exposure to hypobaric hypoxia in low-landers and in high-landers permanently exposed to hypobaric hypoxia (see Hoppeler et al. 2003). Perhaps this low oxidative capacity and mitochondrial volume density is due to a hypoxia-induced transition to fast fibres because fast fibres have low oxidative capacity and low mitochondrial volume density. This raises the possibility that CIH and CIA could be responsible for the changes in UA muscle structure observed in OSA. Therefore, we set out to determine the effects of 5 weeks of intermittent hypoxia and asphyxia on UA muscle (geniohyoid and sternohyoid muscle) structure and function. We chose these two muscles as representative UA muscles because they play an important role in determining UA patency (Brouillette & Thach, 1979), because they are anatomically readily accessible and have fibres running in a uniform direction and because both muscles have been shown to have abnormal morphology in the English bulldog (Petrof et al. 1994)
We found (McGuire et al. 2002a) that CIH had no effect on geniohyoid (Fig. 3A) or sternohyoid (Fig. 3B) fibre-type distribution or on force production (Figs 4A and 5A), but caused an increase in fatigability of both muscles (Figs 4B and C, and 5B and C; geniohyoid muscle tension decreased to 46.4 ± 2.1% of initial tension after 5 min of fatigue for control and to 41.5 ± 3.3% for CIH, and sternohyoid muscle tension decreased to 33.5 ± 1.7% of initial tension after 5 min of fatigue for control and to 27.2 ± 2.9% for CIH). CIA caused a small increase in fast fibres in the geniohyoid (Fig. 6A) but reduced fast fibres in the sternohyoid (Fig. 6B). It had no effect on force production in either muscle but increased geniohyoid fatigability (Fig. 7A and B, tension decreased to 50.5 ± 6.6% of initial tension after 5 min of fatigue for control and to 43.6 ± 5.8% for CIA) and decreased sternohyoid fatigability (Fig. 7C and D, tension decreased to 31.5 ± 5.2% of initial tension after 5 min of fatigue for control and to 37.8 ± 6.0% for CIH) (McGuire et al. 2002b).
|
|
|
|
|
|
|
|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Bernardi L (2001). Interval hypoxic training. Adv Exp Med Biol 502, 377399.[Medline]
Bigard AX, Brunet A, Guezennec CY & Monod H (1991). Effects of chronic hypoxia and endurance training on muscle capillarity in rats. Pflugers Arch 419, 225229.[CrossRef][Medline]
Bradley TD, Rutherford R, Grossman RF, Lue F, Zamel N, Moldofsky H & Phillipson EA (1985). Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis 131, 835839.[Medline]
Brouillette
RT
&
Thach
BT (1979). A neuromuscular mechanism maintaining extrathoracic airway patency. J Appl Physiol
46, 772779.
Chaouat
A, Weitzenblum
E, Krieger
J, Oswald
M
&
Kessler
R (1996). Pulmonary haemodynamics in the obstructive sleep apnoea syndrome. Results in 220 patients. Chest
109, 380386.
Cottrell JJ (1986). Altitude exposures during aircraft flight: flying higher. Chest 92, 8284.
Dempsey
JA, Hanson
PG
&
Henderson
KS (1984). Exercise-induced arterial hypoxemia in healthy human subjects at sea level. J Physiol
355, 161175.
Dunleavy M & Bradford A (2003). Chronic intermittent hypoxia does not promote cardiac arrhythmogenesis. Ir J Med Sci (in press).
Dunleavy M, Dooley M, Cox D & Bradford A (2003). Effect of chronic intermittent asphyxia on platelet function. J Physiol P, 88P.
Elsner R (1989). Perspectives in diving and asphyxia. Undersea Biomed Res 16, 339344.[Medline]
Fagan
KA (2001). Pulmonary hypertension in mice following intermittent hypoxia. J Appl Physiol
90, 25022507.
Fletcher
EC
&
Bao
G (1996). Effect of eucapnic and hypocapnic hypoxia on systemic blood pressure in hypertension-prone rats. J Appl Physiol
81, 20882094.
Fletcher
EC, Bao
G
&
Miller
CC
III (1995). Effect of recurrent episodic hypocapnic, eucapnic and hypercapnic hypoxia on systemic blood pressure. J Appl Physiol
78, 15161521.
Fletcher
EC, Lesske
J, Behm
R, Miller
CC
III, Stauss
H
&
Unger
T (1992a). Carotid chemoreceptors, systemic blood pressure and chronic episodic hypoxia mimicking sleep apnea. J Appl Physiol
72, 19781984.
Fletcher
EC, Lesske
J, Culman
J, Miller
CC
III
&
Unger
T (1992b). Sympathetic denervation blocks blood pressure elevation in episodic hypoxia. Hypertension
20, 612619.
Fletcher
EC, Lesske
J, Qian
W, Miller
CC
III
&
Unger
T (1992c). Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension
19, 555561.
Goldman JM, Ireland RM, Berthon-Jones M, Grunstein RR, Sullivan CE & Biggs JC (1991). Erythropoietin concentrations in obstructive sleep apnea. Thorax 46, 2527.[Abstract]
Guilleminault C, Tilkian A & Dement WC (1976). The sleep apnea syndromes. Annu Rev Med 27, 465484.[CrossRef][Medline]
Hoffstein
V, Herridge
M, Mateike
S, Redline
S
&
Strohl
KP (1994). Hematocrit levels in sleep apnea. Chest
106, 787791.
Hoppeler H, Vogt M, Weibel ER & Fluck M (2003). Response of skeletal muscle mitochondria to hypoxia. Exp Physiol 88, 109119.[Abstract]
Hurtado A (1960). Some clinical aspects of life at high altitude. Ann Intern Med 53, 247258.
Kripke DF, Ancoli-Israel S, Klauber MR, Wingard DI, Mason WJ & Mullaney DJ (1997). Prevalence of sleep-disordered breathing in ages 4064 years: a population-based survey. Sleep 20, 6576.[Medline]
Laks L, Lehrhaft B, Grunstein RR & Sullivan CE (1995). Pulmonary hypertension in obstructive sleep apnoea. Eur Respir J 8, 537541.[Abstract]
Lavie P, Ben-Yosef R & Rubin AE (1985). Prevalence of sleep apnea syndrome among patients with essential hypertension. Am J Cardiol 55, 10191022.[CrossRef][Medline]
McGuire M & Bradford A (1999). Chronic intermittent hypoxia increases haematocrit and causes right ventricular hypertrophy in the rat. Respir Physiol 117, 5358.[CrossRef][Medline]
McGuire
M
&
Bradford
A (2001). Chronic intermittent hypercapnic hypoxia increases pulmonary arterial pressure and haematocrit in rats. Eur Respir J
18, 279285.
McGuire
M, MacDermott
M
&
Bradford
A (2002a). The effects of chronic episodic hypoxia on rat upper airway muscle contractile properties and fiber-type distribution. Chest
122, 10121017.
McGuire
M, MacDermott
M
&
Bradford
A (2002b). The effects of chronic episodic hypercapnic hypoxia on rat upper airway muscle contractile properties and fiber-type distribution. Chest
122, 14001406.
McGuire
M, MacDermott
M
&
Bradford
A (2003). Effects of chronic intermittent asphyxia on rat diaphragm and limb muscle contractility. Chest
123 (3), 875881.
McNicholas WT (1990). Sleep apnoea. J Ir Coll Physicians Surg 19, 5356.
McNicholas WT, Bowes G, Zamel N & Phillipson EA (1984). Impaired detection of added inspiratory resistance in patients with obstructive sleep apnea. Am Rev Respir Dis 129, 4548.[Medline]
Marshall BE & Wyche MQ (1972). Hypoxemia during and after general anaesthesia. Anesthesiology 37, 178184.[CrossRef][Medline]
Martial FP, Dunleavy M, Jones JFX, Nolan P, O'Regan RG, McNicholas W & Bradford A (2003). Activity of dorsal medullary respiratory neurons in awake rats. Adv Exp Med Biol 536, 445443.[Medline]
McNicholas WT, Coffey M, McDonnell T, O'Regan RG & Fitzgerald MX (1987). Upper airway obstruction during sleep in normal subjects after selective topical oropharyngeal anesthesia. Am Rev Respir Dis 135, 13161319.[Medline]
Moore-Gillon JC & Cameron IR (1985). Right ventricular hypertrophy and polycythaemia in rats after intermittent exposure to hypoxia. Clin Sci 6, 595599.
Nattie EE & Doble EA (1984). Threshold of intermittent hypoxia-induced right ventricular hypertrophy in the rat. Respir Physiol 56, 253259.[CrossRef][Medline]
O'Halloran
KD, McGuire
M, O'Hare
T
&
Bradford
A (2002). Chronic intermittent asphyxia impairs rat upper airway muscle responses to acute hypoxia and asphyxia. Chest
122, 269275.
Ooi
H, Cadogan
E, Sweeney
M, Howell
K, O'Regan
RG
&
McLoughlin
P (2000). Chronic hypercapnia inhibits hypoxic pulmonary vascular remodelling. Am J Physiol Heart Circ Physiol
278, H331338.
Petrof
BJ, Pack
AI, Kelly
AM, Eby
J
&
Hendricks
JC (1994). Pharyngeal myopathy of loaded upper airway in dogs with sleep apnoea. J Appl Physiol
76, 17461752.
Rabinovitch M, Gamble W, Nadas AS, Miettinen OS & Reid L (1979). Rat pulmonary circulation after chronic hypoxia: haemodynamic and structural features. Am J Physiol 236, 818827.
Remmers
JE, deGroot
WJ, Sauerland
EK
&
Anch
AM (1978). Pathogenesis of upper airway occlusion during sleep. J Appl Physiol
44, 931938.
Sajkov D, Cowie RJ, Thornton AT, Espinoza HA & McEvoy RD (1994). Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 149, 416422.[Abstract]
Sanner BM, Doberauer C, Konermann M, Sturm A & Zidek W (1997). Pulmonary hypertension in patients with obstructive sleep apnea syndrome. Arch Intern Med 157, 24832487.[Abstract]
Serebrovskya TV (2002). Intermittent hypoxia research in the former Soviet Union and the Commonwealth of Independent States: history and review of the concept and selected applications. High Alt Med Biol 3, 205221.[CrossRef][Medline]
Series F, Cote C, Simoneau J-A, Jelinas Y, St. Pierre S, Leclerc J, Ferland R & Marc I (1995). Physiologic, metabolic, and muscle fiber type characteristics of musculus uvulae in sleep apnea hypopnea syndrome and in snorers. J Clin Invest 95, 2025.
Series F, Simoneau J-A, St. Pierre S & Marc I (1996). Characteristics of the genioglossus and musculus uvulae in sleep apnea hypopnea syndrome and in snorers. Am J Respir Crit Care Med 153, 18701874.[Abstract]
Stauffer JL, Buick MK, Bixler EO, Sharkey FE, Abt AB, Manders EK, Kales A, Cadieux RJ, Barry JD & Zwillich CW (1999). Morphology of the uvula in obstructive sleep apnea. Am Rev Respir Dis 140, 724728.
Thach BT (1985). Sleep apnea in infancy and childhood. Med Clin North Am 69, 12891315.[Medline]
Vgontzas
AN, Papanicolaou
DA, Bixler
EO, Hopper
K, Lotsikas
A, Lin
HM, Kales
A
&
Chrousos
GP (2000). Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance and hypercytokinemia. J Clin Endocrinol Metab
85, 11511158.
Weitzenblum E, Krieger J, Apprill M, Vallee E, Ehrhart M, Ratomaharo J, Oswald M & Kurtz D (1988). Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 138, 345349.[Medline]
Young
T, Palta
M, Dempsey
J, Skatrud
J, Weber
S
&
Bader
S (1993). The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med
328, 12301235.
This article has been cited by other articles:
![]() |
T. V. Serebrovskaya, E. B. Manukhina, M. L. Smith, H. F. Downey, and R. T. Mallet Intermittent Hypoxia: Cause of or Therapy for Systemic Hypertension? Experimental Biology and Medicine, June 1, 2008; 233(6): 627 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Joyeux-Faure, F. Stanke-Labesque, B. Lefebvre, P. Beguin, D. Godin-Ribuot, C. Ribuot, S. H. Launois, G. Bessard, and P. Levy Chronic intermittent hypoxia increases infarction in the isolated rat heart J Appl Physiol, May 1, 2005; 98(5): 1691 - 1696. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Allahdadi, B. R. Walker, and N. L. Kanagy Augmented Endothelin Vasoconstriction in Intermittent Hypoxia-Induced Hypertension Hypertension, April 1, 2005; 45(4): 705 - 709. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.-K. Pae, J. Wu, D. Nguyen, R. Monti, and R. M. Harper Geniohyoid muscle properties and myosin heavy chain composition are altered after short-term intermittent hypoxic exposure J Appl Physiol, March 1, 2005; 98(3): 889 - 894. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Hartsfield, I. F. McMurtry, D. D. Ivy, K. G. Morris, S. Vidmar, D. M. Rodman, and K. A. Fagan Cardioprotective and vasomotor effects of HO activity during acute and chronic hypoxia Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2009 - H2015. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |